Prevention of Angiotensin II-Mediated Renal Oxidative Stress, Inflammation, and Fibrosis by Angiotensin-Converting Enzyme 2

被引:182
作者
Zhong, JiuChang
Guo, Danny
Chen, Christopher B.
Wang, Wang [5 ]
Schuster, Manfred [2 ]
Loibner, Hans [2 ]
Penninger, Josef M. [3 ]
Scholey, James W. [4 ]
Kassiri, Zamaneh [5 ]
Oudit, Gavin Y. [1 ,5 ]
机构
[1] Univ Alberta, Mazankowski Alberta Heart Inst, Dept Med, Div Cardiol, Edmonton, AB T6G 2S2, Canada
[2] Apeiron Biol, Vienna, Austria
[3] Austrian Acad Sci, Inst Mol Biotechnol, A-1010 Vienna, Austria
[4] Univ Toronto, Dept Med, Div Nephrol, Toronto, ON, Canada
[5] Univ Alberta, Dept Physiol, Edmonton, AB T6G 2S2, Canada
基金
中国国家自然科学基金;
关键词
angiotensin I; hypertension I; renal fibrosis; signal transduction; CHRONIC KIDNEY-DISEASE; PROXIMAL TUBULAR CELLS; INDUCED HYPERTENSION; PATHOLOGICAL HYPERTROPHY; ACE2; INJURY; EXPRESSION; MICE; DYSFUNCTION; INHIBITION;
D O I
10.1161/HYPERTENSIONAHA.110.164244
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Angiotensin-converting enzyme 2 (ACE2) is a monocarboxypeptidase capable of metabolizing angiotensin (Ang) II into Ang 1 to 7. We hypothesized that ACE2 is a negative regulator of Ang II signaling and its adverse effects on the kidneys. Ang II infusion (1.5 mg/kg(-1)/d(-1)) for 4 days resulted in higher renal Ang II levels and increased nicotinamide adenine dinucleotide phosphate oxidase activity in ACE2 knockout (Ace2(-/y)) mice compared to wild-type mice. Expression of proinflammatory cytokines, interleukin-1 beta and chemokine (C-C motif) ligand 5, were increased in association with greater activation of extracellular-regulated kinase 1/2 and increase of protein kinase C-alpha levels. These changes were associated with increased expression of fibrosis-associated genes (alpha-smooth muscle actin, transforming growth factor-beta, procollagen type I alpha 1) and increased protein levels of collagen I with histological evidence of increased tubulointerstitial fibrosis. Ang II-infused wild-type mice were then treated with recombinant human ACE2 (2 mg/kg(-1)/d(-1), intraperitoneal). Daily treatment with recombinant human ACE2 reduced Ang II-induced pressor response and normalized renal Ang II levels and oxidative stress. These changes were associated with a suppression of Ang II-mediated activation of extracellular-regulated kinase 1/2 and protein kinase C pathway and Ang II-mediated renal fibrosis and T-lymphocyte-mediated inflammation. We conclude that loss of ACE2 enhances renal Ang II levels and Ang II-induced renal oxidative stress, resulting in greater renal injury, whereas recombinant human ACE2 prevents Ang II-induced hypertension, renal oxidative stress, and tubulointerstitial fibrosis. ACE2 is an important negative regulator of Ang II-induced renal disease and enhancing ACE2 action may have therapeutic potential for patients with kidney disease. (Hypertension. 2011;57:314-322.). Online Data Supplement
引用
收藏
页码:314 / U338
页数:18
相关论文
共 50 条
[21]   Vascular Angiotensin-Converting Enzyme 2 Lord of the Ring? [J].
Batlle, Daniel ;
Wysocki, Jan ;
Khan, Mirza S. .
CIRCULATION RESEARCH, 2010, 107 (07) :822-824
[22]   Renal angiotensin-converting enzyme and blood pressure control [J].
Bernstein, Kenneth E. ;
Giani, Jorge F. ;
Shen, Xiao Z. ;
Gonzalez-Villalobos, Romer A. .
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2014, 23 (02) :106-112
[23]   Postconditioning attenuates coronary perivascular and interstitial fibrosis through modulating angiotensin II receptors and angiotensin-converting enzyme 2 after myocardial infarction [J].
Wang, Zhang-Feng ;
Wang, Ning-Ping ;
Harmouche, Suzanna ;
Philip, Tiji ;
Pang, Xue-Fen ;
Bai, Feng ;
Zhao, Zhi-Qing .
JOURNAL OF SURGICAL RESEARCH, 2017, 211 :178-190
[24]   Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 201p [J].
Sanchis-Gomar, Fabian ;
Lavie, Carl J. ;
Perez-Quilis, Carme ;
Henry, Brandon M. ;
Lippi, Giuseppe .
MAYO CLINIC PROCEEDINGS, 2020, 95 (06) :1222-1230
[25]   Angiotensin-Converting Enzyme 2 Suppresses Pathological Hypertrophy, Myocardial Fibrosis, and Cardiac Dysfunction [J].
Zhong, JiuChang ;
Basu, Ratnadeep ;
Guo, Danny ;
Chow, Fung L. ;
Byrns, Simon ;
Schuster, Manfred ;
Loibner, Hans ;
Wang, Xiu-hua ;
Penninger, Josef M. ;
Kassiri, Zamaneh ;
Oudit, Gavin Y. .
CIRCULATION, 2010, 122 (07) :717-U40
[26]   Pancreatic angiotensin-converting enzyme 2 improves glycemia in angiotensin II-infused mice [J].
Chhabra, Kavaljit H. ;
Xia, Huijing ;
Pedersen, Kim Brint ;
Speth, Robert C. ;
Lazartigues, Eric .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2013, 304 (08) :E874-E884
[27]   Angiotensin-Converting Enzyme Inhibitor (ACEI)-Mediated Amelioration in Renal Fibrosis Involves Suppression of Mast Cell Degranulation [J].
Sun, Nan ;
Zhai, Lei ;
Li, Hui ;
Shi, Li-Hua ;
Yao, Zhi ;
Zhang, Bo .
KIDNEY & BLOOD PRESSURE RESEARCH, 2016, 41 (01) :108-118
[28]   Conversion of Aβ43 to Aβ40 by the Successive Action of Angiotensin-Converting Enzyme 2 and Angiotensin-Converting Enzyme [J].
Liu, Shuyu ;
Liu, Junjun ;
Miura, Yukie ;
Tanabe, Chiaki ;
Maeda, Tomoji ;
Terayama, Yasuo ;
Turner, Anthony J. ;
Zou, Kun ;
Komano, Hiroto .
JOURNAL OF NEUROSCIENCE RESEARCH, 2014, 92 (09) :1178-1186
[29]   Angiotensin-Converting Enzyme 2 Activation Is Not a Common Feature of Angiotensin-Converting Enzyme Inhibitory Peptides [J].
Wang, Zihan ;
Fan, Hongbing ;
Bao, Xiaoyu ;
Wu, Jianping .
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2023, 71 (23) :8867-8876
[30]   Angiotensin-converting enzyme 2 activity in patients with chronic kidney disease [J].
Roberts, Matthew A. ;
Velkoska, Elena ;
Ierino, Francesco L. ;
Burrell, Louise M. .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 (09) :2287-2294